# Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies

> **NCT05210062** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 70 (estimated)

## Conditions studied

- Depression
- Mania
- Hallucinations

## Interventions

- **OTHER:** Iterative exposure to suxamethonium during ECT sessions

## Key facts

- **NCT ID:** NCT05210062
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-27
- **Primary completion:** 2023-09
- **Final completion:** 2023-09
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05210062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05210062, "Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05210062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*